StockWatch
·

Dr. Lal PathLabs Ltd

BSE: 539524

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
0.97264.23527.48790.73Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
11.4618.7326.0033.27Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue675.20+6.8%632.10-9.6%699.60+9.2%640.70+11.0%577.20+9.3%528.10-9.6%583.90
Other Income37.00+39.1%26.60+16.7%22.80-13.3%26.30+4.4%25.20-14.6%29.50+34.1%22.00
Total Income712.20+8.1%658.70-8.8%722.40+8.3%667.00+10.7%602.40+8.0%557.60-8.0%605.90
EXPENSES
Expenditure542.30+7.3%505.50-4.2%527.60+6.7%494.60+8.1%457.50+12.6%406.40-3.8%422.60
Tax28.80-7.1%31.00-36.9%49.10+13.9%43.10+1331.4%-3.50-109.5%36.70-23.7%48.10
PROFIT
PBT169.90+38.0%123.10-36.8%194.80+13.0%172.40+19.0%144.90-4.2%151.20-17.5%183.30
Net Profit141.10+53.2%92.10-36.8%145.70+12.7%129.30-12.9%148.40+29.6%114.50-15.3%135.20
KEY METRICS
OPM %26.88%+4.16pp22.72%-8.03pp30.75%+2.13pp28.62%+1.06pp27.56%+9.00pp18.56%-5.09pp23.65%
NPM %19.81%+5.83pp13.98%-6.19pp20.17%+0.78pp19.39%-5.24pp24.63%+4.10pp20.53%-1.78pp22.31%
EPS8.45+53.1%5.52-68.4%17.46+12.6%15.51-12.9%17.80+29.5%13.74-15.4%16.24

Corporate Events

Board MeetingLALPATHLAB
2026
30Apr

Board Meeting

To consider and approve the Audited (Standalone & Consolidat…

BSE Filing
Board MeetingLALPATHLAB
2026
30Jan

Board Meeting

Update on board meeting, Consider and approve the Un-audited…

BSE Filing
BonusLALPATHLAB
2025
19Dec

1:1

BSE Filing
Board MeetingLALPATHLAB
2024
23Oct

Board Meeting

Approval Of The Un-Audited (Standalone & Consolidated) Finan…

BSE Filing
DividendLALPATHLAB
2024
20Aug

₹6 / share

BSE Filing
DividendLALPATHLAB
2024
10Jun

₹6 / share

BSE Filing
Board MeetingLALPATHLAB
2024
10May

Board Meeting

Consider and approve Audited (Standalone & Consolidated) Fin…

BSE Filing
DividendLALPATHLAB
2024
13Feb

₹12 / share

BSE Filing
Board MeetingLALPATHLAB
2024
1Feb

Board Meeting

Consideration and approval of Un-audited Financial Results f…

BSE Filing
Board MeetingLALPATHLAB
2023
2Nov

Board Meeting

consider and approve unaudited financial results for the Qua…

BSE Filing